Potential for dose escalation in the postprostatectomy setting with intensity-modulated radiation therapy: A dosimetric study using EORTC consensus guidelines for target volume contours

Practical Radiation Oncology

Volumn 1, Issue 2, 2011, Pages 105-114

  Harrison, Amy ^a   Studenski, Matthew ^a   Harvey, Arthur ^a   Trabulsi, Edouard J ^a   Xiao, Ying ^a   Yu, Yan ^a   Dicker, Adam P ^a   Showalter, Timothy N ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONE BEAM COMPUTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MALE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RADIATION DOSE ESCALATION;

EID: 80053600923     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2010.10.005     Document Type: Article

References (45)

1. Wiegel T., Bottke D., Steiner U., et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. JClin Oncol 2009, 27:2924-2930.
2. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005, 366:572-578.
3. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006, 296:2329-2335.
4. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009, 181:956-962.
5. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004, 291:1325-1332.
6. Trock B.J., Han M., Freedland S.J., et al. Prostate cancer-specific survival following salvage radiotherapy vs. observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008, 299:2760-2769.
7. Neuhof D., Hentschel T., Bischof M., et al. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Int J Radiat Oncol Biol Phys 2007, 67:1411-1417.
8. Anscher M.S., Clough R., Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. Int J Radiat Oncol Biol Phys 2000, 48:369-375.
9. Valicenti R.K., Gomella L.G., Ismail M., et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 1998, 42:501-506.
10. Ost P., Fonteyne V., Villeirs G., et al. Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients. Eur Urol 2009, 56:669-677.
11. Bernard J.R., Buskirk S.J., Heckman M.G., et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys 2010, 76:735-740.
12. King C.R., Kapp D. Radiotherapy after prostatectomy: is the evidence for dose escalation out there?. Int J Radiat Oncol Biol Phys 2008, 71:346-350.
13. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
14. Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 2010, 28:1106-1111.
15. Shipley W.U., Verhey U., Munzenrider J.E., et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995, 32:3-12.
16. Kuban DA, Levy LB, Cheung MR, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? [Epub ahead of print May 20, 2010]. Int J Radiat Oncol Biol Phys.
17. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:1124-1129.
18. Bastasch M.D., Teh B.S., Mai W.Y., et al. Post-nerve sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys 2002, 54:101-106.
19. Sandhu A., Sethi R., Rice R., et al. Prostate bed localization with image-guided approach using on-board imaging: reporting acute toxicity and implications for radiation therapy planning following prostatectomy. Radiother Oncol 2008, 88:20-25.
20. Teh B.S., Wei-Yuan M., Augspurger M.E., et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001, 49:465-472.
21. Koontz B.F., Das S., Temple K., et al. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy. Med Dosim 2009, 34:256-260.
22. Sanguineti G., Castellone P., Foppiano F., et al. Anatomic variations due to radical prostatectomy: impact on target volume definition and dose-volume parameters of rectum and bladder. Strahlenther Onkol 2004, 180:563-572.
23. Fiorino C., Foppiano F., Franzone P., et al. Rectal and bladder motion during conformal radiotherapy after radical prostatectomy. Radiother Oncol 2005, 74:187-195.
24. Poortmans P., Bossi A., Vandeputte K., et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol 2007, 84:121-127.
25. Alongi F., Fiorino C., Cozzarini C., et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009, 93:207-212.
26. Wong G.W., Palazzi-Churas K.L., Jarrard D.F., et al. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys 2008, 70:449-455.
27. De Meerleer G., Fonteyne V., Meersschout S., et al. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008, 89:205-213.
28. Showalter T.N., Nawaz A.O., Xiao Y., et al. A cone beam CT-based study for clinical target definition using pelvic anatomy during post-prostatectomy radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:431-436.
29. Michalski J.M., Lawton C., Naqa I.E., et al. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010, 76:361-368.
30. King C.R., Spiotto M.T. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. Int J Radiat Oncol Biol Phys 2008, 71:23-27.
31. Rong Y., Smilowitz J., Tewatia D., et al. Dose calculation on kv cone beam ct images: an investigation of the hu-density conversion stability and dose accuracy using the site-specific calibration. Med Dosim 2010, 35:195-207.
32. Jeng S.-C., Tsai C.-L., Chan W.-T., et al. Mathematical estimation and in vivo dose measurement for cone-beam computed tomography on prostate cancer patients. Radiother Oncol 2009, 92:57-61.
33. Guan H., Dong H. Dose calculation accuracy using cone-beam CT (CBCT) for pelvic adaptive radiotherapy. Phys Med Biol 2009, 54:6239-6250.
34. Dicker A.P., Sweet J.W., Valicenti R.K., et al. Definition of the target volume after radical prostatectomy based on CT driven image fusion technology: implications for post-operative radiation therapy. American Society for Therapeutic Radiation Oncology Annual Meeting 1997.
35. Foppiano F., Fiorino C., Frezza G., et al. The impact of contouring uncertainty on rectal 3D dose-volume data: results of a dummy run in a multicenter trial (AIROPROS01-02). Int J Radiat Oncol Biol Phys 2003, 57:573-579.
36. Trabulsi E.J., Valicenti R.K., Hanlon A.L., et al. A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. Urology 2008, 72:1298-1302.
37. Peterson J.L., Buskirk S.J., Heckman M.G., et al. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol 2009, 93:203-206.
38. Wiltshire K.L., Brock K.K., Haider M.A., et al. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys 2007, 69:1090-1099.
39. Miralbell R., Vees H., Lozano J., et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys 2007, 67:356-361.
40. Sidhom M.A., Kneebone A.B., Lehman M., et al. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol 2008, 88:10-19.
41. Viswanathan A.N., Yorke E.D., Marks L.B., et al. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010, 76:S116-S122.
42. Fiorino C., Rancati T., Valdagni R. Predictive models of toxicity in external radiotherapy. Cancer 2009, 115:3135-3140.
43. Cheung R., Tucker S.L., Dong L., et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007, 67:1059-1065.
44. Michalski J.M., Gay H., Jackson A., et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010, 76:S123-S129.
45. Krupski T.L., Foley K.A., Baser O., et al. Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol 2007, 178:1423-1428.